Latest cancer therapies Stories
Researchers at Mount Sinai School of Medicine, the University of Manchester, and the MD Anderson Cancer Center have found a new role for an oncogenic signaling pathway in embryonic stem cell (ESC)
An inexpensive "orphan drug" used to treat sleep disorders appears to be a potent inhibitor of cancer cells.
Researchers at UC Santa Barbara have discovered a molecular pathway that may explain how a particularly deadly form of cancer develops.
Cancer is one of the most common causes of death in humans.
LOS ANGELES, July 21, 2011 /PRNewswire/ -- Genesis Biopharma, Inc. (OTC/BB: GNBP), a biotechnology company developing targeted cancer therapies, today announced it has named retired four-star General Merrill A. McPeak to its Board of Directors. General McPeak served nearly four decades in the U.S.
SANTA ROSA, Calif., July 19, 2011 /PRNewswire/ -- Researchers at Indiana University and Methodist Research Institute have published the dramatic effects of a natural formula against breast cancer.
LOS ANGELES, July 18, 2011 /PRNewswire/ -- Genesis Biopharma, Inc. (OTC/BB: GNBP), a biotechnology company developing targeted cancer therapies, today announced it has named David Voyticky to its Board of Directors. Mr.
LOS ANGELES, July 5, 2011 /PRNewswire/ -- Genesis Biopharma, Inc.
- A person or thing gazed at with wonder or curiosity, especially of a scornful kind.